Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 — Dallas, Texas

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400?

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 conducted?

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 accredited by Crixeo Health?

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.